Eleonora De Martin
Eleonora De Martin is an expert in Hepatology at Centre Hépato-Biliaire (France). Eleonora De Martin has authored 120 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 2 of them ongoing. SLR score: 485 (community average: 125). How the SLR is computed.
LeadR Profile
Hepatology
Subspecialties: Gastroenterology - Transplantation - Oncology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2013 - 2026
Number : 120
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Is it too early to dismiss corticosteroids in CDK4/6 inhibitor-induced liver injury? PMID 42508615 — adrenal cortex hormones, liver | JHEP Rep | 2026 | 0 |
| Post-transplant alloimmune liver disease in bile salt export pump deficiency: A multicenter study. PMID 42501969 — liver diseases, liver transplantation, bile, antibodies, plasmapheresis, liver, rituximab, atp binding cassette transporter, subfamily b, member 11, genotype, transplants, therapeutics, transplantation | JHEP Rep | 2026 | 0 |
| The 2024 International Liver Transplant Society and International Liver Cancer Association Consensus Recommendations for Liver Transplantation for Liver Cancer. PMID 42312290 — liver transplantation, neoplasms, liver, liver neoplasms, transplants, therapeutics, transplantation | Liver Cancer | 2026 | 0 |
| Complete immunosuppression withdrawal after liver transplantation: An International Multicenter Study. PMID 42263796 — liver transplantation, mortality, fibrosis, tacrolimus, liver, calcineurin inhibitors, transplants, immunosuppression therapy, transplantation, weaning | Clin Gastroenterol Hepatol | 2026 | 0 |
| Graft and Patient Survival After Liver Transplantation for Primary Sclerosing Cholangitis: A French National Cohort Study. PMID 41816929 — liver transplantation, cholangitis, neoplasms, cohort studies, liver, cholangitis, sclerosing, transplants, colorectal neoplasms, transplantation, cholangiocarcinoma | Liver Int | 2026 | 0 |
Clinical Studies 4
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 2
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| The MAI FOIE Cohort NCT07594990 — liver diseases, liver, biomarkers | N/A | Not yet recruiting | 2026 |
| Validation of a Prognostic Score for Steroid Therapy Response in Acute Severe Autoimmune Hepatitis NCT05473403 — liver diseases, hepatitis, autoimmune, liver transplantation, organ dysfunction scores, emergencies, adrenal cortex hormones, liver, hepatitis a, risk factors, liver failure, acute, therapeutics, steroids, transplantation, hepatitis, liver failure, non-responder | N/A | Not yet recruiting | 2024 |
LeadR Networks
Main global connection map